AIL
HZNP

AGF Investments LLC’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

AGF Investments LLC’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-308
Closed -$23K – 535
2020
Q4 		$23K Sell
308
-52
-14% -$3.87K ﹤0.01% 393
2020
Q3 		$28K Sell
360
-8,226
-96% -$566K ﹤0.01% 386
2020
Q2 		$477K Buy
8,586
+3,097
+56% +$132K 0.05% 297
2020
Q1 		$163K Sell
5,489
-21,273
-79% -$720K 0.02% 382
2019
Q4 		$969K Buy
26,762
+26,186
+4,546% +$803K 0.18% 147
2019
Q3 		$16K Sell
576
-250
-30% -$6.46K ﹤0.01% 473
2019
Q2 		$20K Sell
826
-384
-32% -$9.74K ﹤0.01% 460
2019
Q1 		$32K Sell
1,210
-1,083
-47% -$25.7K 0.01% 409
2018
Q4 		$45K Buy
2,293
+128
+6% +$2.51K 0.01% 444
2018
Q3 		$41K Sell
2,165
-334
-13% -$6.35K 0.01% 440
2018
Q2 		$42 Buy
+2,499
New +$38.1K ﹤0.01% 392
2017
Q2 		– Sell
-580
Closed -$9K – 806
2017
Q1 		$9K Buy
+580
New +$9.39K ﹤0.01% 662

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AGF Investments LLC's HZNP Position: Q1 2021 in Review

AGF Investments LLC sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2021, closing a stake of 308 shares — an estimated $23K sold.

AGF Investments LLC first reported a position in HZNP in Q1 2017 and held it in 12 quarters. The position peaked at $969K in Q4 2019. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

  • AGF Investments LLC reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • AGF Investments LLC sold 308 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $23K.
  • AGF Investments LLC first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2017 and held it in 12 quarters.
  • AGF Investments LLC's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $969K in Q4 2019.
  • 516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on AGF Investments LLC's 13F filing for Q1 2021, filed 14 May 2021.